We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$3.28B
AUM Growth
+$597M
Cap. Flow
+$166M
Cap. Flow %
5.04%
Top 10 Hldgs %
22.55%
Holding
268
New
71
Increased
59
Reduced
39
Closed
90

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$77.8M
2
HST icon
Host Hotels & Resorts
HST
+$67.9M
3
WYNN icon
Wynn Resorts
WYNN
+$64.1M
4
IP icon
International Paper
IP
+$63.6M
5
AAP icon
Advance Auto Parts
AAP
+$56.4M

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$58.5M
2
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
+$57.9M
3
TNL icon
Travel + Leisure Co
TNL
+$56M
4
ONIT
Onity Group
ONIT
+$44.1M
5
EXP icon
Eagle Materials
EXP
+$42.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.75%
2 Healthcare 13.67%
3 Technology 10.55%
4 Financials 10.48%
5 Materials 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABEV icon
76
Ambev
ABEV
$47.3B
$14.2M 0.43%
+1,938,031
New +$14.2M
HAL icon
77
Halliburton
HAL
$27.9B
$14M 0.43%
275,939
+250,996
+1,006% +$13M
WHR icon
78
Whirlpool
WHR
$2.42B
$13.2M 0.4%
84,000
-56,000
-40% -$8.21M
MOS icon
79
The Mosaic Company
MOS
$7.09B
$13M 0.4%
275,000
-61,576
-18% -$2.86M
AGO icon
80
Assured Guaranty
AGO
$3.78B
$12.7M 0.39%
536,980
+236,080
+78% +$5.13M
AGN
81
DELISTED
Allergan plc
AGN
$12.6M 0.38%
75,100
+20,372
+37% +$3.18M
AXE
82
DELISTED
Anixter International Inc
AXE
$12.6M 0.38%
+140,312
New +$12.2M
HBI
83
DELISTED
Hanesbrands
HBI
$12.3M 0.37%
+700,000
New +$11.6M
ASH icon
84
Ashland
ASH
$3.04B
$12M 0.36%
+251,780
New +$11.3M
TXT icon
85
Textron
TXT
$16.6B
$11.2M 0.34%
+303,668
New +$9.32M
MCK icon
86
McKesson
MCK
$98.5B
$10.9M 0.33%
67,457
-18,050
-21% -$2.77M
RGC
87
DELISTED
Regal Entertainment Group
RGC
$10.7M 0.33%
+550,000
New +$10.5M
BRO icon
88
Brown & Brown
BRO
$22.9B
$10.7M 0.33%
681,028
+205,324
+43% +$3.25M
MTG icon
89
MGIC Investment
MTG
$6.27B
$10.7M 0.32%
+1,262,247
New +$10.1M
GPK icon
90
Graphic Packaging
GPK
$3.26B
$10.6M 0.32%
1,100,000
+1,002,800
+1,032% +$8.78M
STZ icon
91
Constellation Brands
STZ
$22.2B
$10.6M 0.32%
150,000
-522,960
-78% -$35M
GS icon
92
Goldman Sachs
GS
$313B
$10.1M 0.31%
56,989
+27,584
+94% +$4.55M
CIT
93
DELISTED
CIT Group Inc.
CIT
$9.89M 0.3%
189,717
+127,617
+206% +$6.34M
KATE
94
DELISTED
Kate Spade & Company
KATE
$9.62M 0.29%
300,000
-25,000
-8% -$737K
FCX icon
95
Freeport-McMoran
FCX
$90B
$9.44M 0.29%
250,000
+26,129
+12% +$926K
BWXT icon
96
BWX Technologies
BWXT
$16B
$9.36M 0.28%
+382,563
New +$8.96M
CQB
97
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
$9.07M 0.28%
775,000
+51,657
+7% +$570K
SLM icon
98
SLM Corp
SLM
$4.57B
$8.94M 0.27%
+951,835
New +$8.75M
VTRS icon
99
CALL
Viatris
VTRS
$20.1B
$8.68M 0.26%
+200,000
New +$8.22M
LHO
100
DELISTED
LaSalle Hotel Properties
LHO
$8.64M 0.26%
+280,000
New +$8.56M
2 3
4
5 6

Similar funds

MWAC
Mariner Wealth Advisors (Cincinnati) Cincinnati, Ohio $1.81B AUM 13.11% 1-Year Est. Return
TP
Tesuji Partners Fort Lee, New Jersey $1.73B AUM 3.93% 1-Year Est. Return
PC
Pomelo Capital New York $1.04B AUM 1.25% 1-Year Est. Return
RW
Rand Wealth Baltimore, Maryland $893M AUM 9.85% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
AC
AFAM Capital Austin, Texas $718M AUM 12.09% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Ascend Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Ascend Capital held 268 positions worth $3.28B, up 22% from $2.69B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ascend Capital deployed $166M of net new capital in Q4 2013, opening 71 new positions and adding to 59 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,975,045 shares worth $79.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Liberty Interactive Corporation Series A Liberty Ventures, an estimated $57.9M trimmed.

  • Ascend Capital's largest Q4 2013 buy was Teva Pharmaceuticals: 1,975,045 shares worth $79.2M.
  • Ascend Capital added most to Host Hotels & Resorts in Q4 2013, an estimated $67.9M increase.
  • Ascend Capital's biggest Q4 2013 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $57.9M.
  • Ascend Capital fully exited Perrigo in Q4 2013, selling an estimated $58.5M.
  • Ascend Capital's ten largest holdings make up 23% of its $3.28B portfolio in Q4 2013.
  • Ascend Capital opened 71 new positions and closed 90 in Q4 2013.
  • Ascend Capital's portfolio value rose 22% quarter-over-quarter to $3.28B.

Based on Ascend Capital's 13F filing for Q4 2013, filed 14 Feb 2014.